JP2011524898A5 - - Google Patents

Download PDF

Info

Publication number
JP2011524898A5
JP2011524898A5 JP2011514540A JP2011514540A JP2011524898A5 JP 2011524898 A5 JP2011524898 A5 JP 2011524898A5 JP 2011514540 A JP2011514540 A JP 2011514540A JP 2011514540 A JP2011514540 A JP 2011514540A JP 2011524898 A5 JP2011524898 A5 JP 2011524898A5
Authority
JP
Japan
Prior art keywords
disorder
pharmaceutically acceptable
formula
acceptable salt
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011514540A
Other languages
English (en)
Japanese (ja)
Other versions
JP5468068B2 (ja
JP2011524898A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2009/050763 external-priority patent/WO2009154563A1/en
Publication of JP2011524898A publication Critical patent/JP2011524898A/ja
Publication of JP2011524898A5 publication Critical patent/JP2011524898A5/ja
Application granted granted Critical
Publication of JP5468068B2 publication Critical patent/JP5468068B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011514540A 2008-06-20 2009-06-18 ジベンゾチアゼピン誘導体及びその使用 Expired - Fee Related JP5468068B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20
US61/074,417 2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014011979A Division JP2014098006A (ja) 2008-06-20 2014-01-27 ジベンゾチアゼピン誘導体及びその使用

Publications (3)

Publication Number Publication Date
JP2011524898A JP2011524898A (ja) 2011-09-08
JP2011524898A5 true JP2011524898A5 (cg-RX-API-DMAC10.html) 2012-07-19
JP5468068B2 JP5468068B2 (ja) 2014-04-09

Family

ID=41431860

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011514540A Expired - Fee Related JP5468068B2 (ja) 2008-06-20 2009-06-18 ジベンゾチアゼピン誘導体及びその使用
JP2014011979A Pending JP2014098006A (ja) 2008-06-20 2014-01-27 ジベンゾチアゼピン誘導体及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014011979A Pending JP2014098006A (ja) 2008-06-20 2014-01-27 ジベンゾチアゼピン誘導体及びその使用

Country Status (37)

Country Link
US (3) US20110160184A1 (cg-RX-API-DMAC10.html)
EP (1) EP2307389B1 (cg-RX-API-DMAC10.html)
JP (2) JP5468068B2 (cg-RX-API-DMAC10.html)
KR (1) KR20110019781A (cg-RX-API-DMAC10.html)
CN (1) CN102131791B (cg-RX-API-DMAC10.html)
AR (1) AR072200A1 (cg-RX-API-DMAC10.html)
AU (1) AU2009260905B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0914231A2 (cg-RX-API-DMAC10.html)
CA (1) CA2728675A1 (cg-RX-API-DMAC10.html)
CL (1) CL2010001471A1 (cg-RX-API-DMAC10.html)
CR (1) CR11860A (cg-RX-API-DMAC10.html)
CU (1) CU23884B1 (cg-RX-API-DMAC10.html)
CY (1) CY1113845T1 (cg-RX-API-DMAC10.html)
DK (1) DK2307389T3 (cg-RX-API-DMAC10.html)
DO (1) DOP2010000393A (cg-RX-API-DMAC10.html)
EA (1) EA201001889A1 (cg-RX-API-DMAC10.html)
EC (1) ECSP10010698A (cg-RX-API-DMAC10.html)
ES (1) ES2402084T3 (cg-RX-API-DMAC10.html)
HN (1) HN2010002683A (cg-RX-API-DMAC10.html)
HR (1) HRP20130234T1 (cg-RX-API-DMAC10.html)
IL (2) IL210081A (cg-RX-API-DMAC10.html)
ME (1) ME01516B (cg-RX-API-DMAC10.html)
MX (1) MX2010014203A (cg-RX-API-DMAC10.html)
MY (1) MY157518A (cg-RX-API-DMAC10.html)
NI (1) NI201000224A (cg-RX-API-DMAC10.html)
NZ (1) NZ590616A (cg-RX-API-DMAC10.html)
PE (1) PE20110029A1 (cg-RX-API-DMAC10.html)
PL (1) PL2307389T3 (cg-RX-API-DMAC10.html)
PT (1) PT2307389E (cg-RX-API-DMAC10.html)
RS (1) RS52703B (cg-RX-API-DMAC10.html)
SI (1) SI2307389T1 (cg-RX-API-DMAC10.html)
SV (1) SV2010003769A (cg-RX-API-DMAC10.html)
TW (1) TWI488854B (cg-RX-API-DMAC10.html)
UA (1) UA105903C2 (cg-RX-API-DMAC10.html)
UY (1) UY31919A (cg-RX-API-DMAC10.html)
WO (1) WO2009154563A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201100488B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52703B (sr) * 2008-06-20 2013-08-30 Astrazeneca Ab Derivat dibenzotiazepina i njegova upotreba
US10469472B2 (en) * 2013-08-12 2019-11-05 Cis Maxwell, Llc Operating system integrated domain management
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
WO2015074150A1 (en) 2013-11-21 2015-05-28 Graphite Software Corporation Managed domains for remote content and configuration control on mobile information devices
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use
WO2024184543A1 (en) * 2023-03-08 2024-09-12 Johann Wolfgang Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294355A (cg-RX-API-DMAC10.html)
NL293201A (cg-RX-API-DMAC10.html)
DE1620703B2 (de) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) * 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
DE1620711A1 (de) * 1962-05-25 1970-06-04 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter 5H-Dibenzo[b,e][1,4]diazepine
CH476743A (de) 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von Amidinen der Dibenzo (b,e) (1,4)-diazepin-Reihe
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
BE632120A (cg-RX-API-DMAC10.html) 1963-05-09
US3908010A (en) * 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3884920A (en) * 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3683034A (en) * 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3412193A (en) * 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
US3444169A (en) * 1966-01-17 1969-05-13 American Cyanamid Co Process for 11 - aminodibenz(b,f)(1,4)oxazepines and analogous thiazepines
NL6715650A (cg-RX-API-DMAC10.html) 1966-12-16 1968-06-17
US3852446A (en) * 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3758479A (en) * 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3539573A (en) 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569730A5 (cg-RX-API-DMAC10.html) * 1972-04-04 1975-11-28 Wander Ag Dr A
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
JPH0565257A (ja) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd 多環式化合物及びその用途
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
SK282366B6 (sk) 1994-08-24 2002-01-07 Astra Aktiebolag Spiro-azabicyklická zlúčenina, farmaceutický prípravok s jej obsahom, spôsob prípravy, medziprodukty tohto spôsobu a jej použitie v medicíne
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
WO2000010572A1 (en) * 1998-08-18 2000-03-02 Sepracor Inc. Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
CN1365279A (zh) 1999-07-28 2002-08-21 奥斯瓦尔德·维斯 用于降低身体运动期间耗氧量的制剂
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
WO2002060870A2 (en) 2000-11-17 2002-08-08 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
EP1395567B1 (en) 2001-05-18 2009-01-14 AstraZeneca AB 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
NZ529426A (en) 2001-06-01 2005-07-29 Astrazeneca Ab Spiroazabicyclic heterocyclic amine ligands for nicotinic acetylcholine receptors useful in therapy
CN1553804A (zh) * 2001-07-09 2004-12-08 用于炎性疾病治疗的联合形式
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
WO2003026563A2 (en) 2001-09-27 2003-04-03 Ramot At Tel Aviv University Ltd. Conjugated anti-psychotic drugs and uses thereof
CA2482312A1 (en) 2002-04-18 2003-10-23 Astrazeneca Ab Thienyl compounds
WO2003087102A1 (en) 2002-04-18 2003-10-23 Astrazeneca Ab Furyl compounds
NZ561993A (en) 2002-04-18 2008-09-26 Astrazeneca Ab Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
EP1538906A2 (en) 2002-09-18 2005-06-15 Fmc Corporation Insecticidal tricyclic derivatives
JP2006510697A (ja) * 2002-12-20 2006-03-30 ビーエーエスエフ アクチェンゲゼルシャフト 殺虫性ジベンゾ(ヘテロ)アゼピン誘導体
US20040224942A1 (en) * 2003-01-23 2004-11-11 Weiner David M. Use of N-desmethylclozapine to treat human neuropsychiatric disease
WO2004076431A1 (en) 2003-02-22 2004-09-10 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
DE10310196A1 (de) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
WO2004092135A2 (en) 2003-04-15 2004-10-28 Astrazeneca Substituted benzosulphonamide as potentiators of glutamate receptors
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
DE602004020263D1 (de) * 2003-12-22 2009-05-07 Acadia Pharm Inc Amino-substituierte diaryläa,dücyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen
RU2394030C2 (ru) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
US20060063754A1 (en) 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
BRPI0517423A (pt) 2004-12-27 2008-10-07 Astrazeneca Ab composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
JP2008526839A (ja) * 2005-01-07 2008-07-24 アストラゼネカ・アクチエボラーグ 11−ピペラジン−1−イルジベンゾ[b,f][1,4]チアゼピン又はその薬学的に許容される塩の新規な使用及び経口医薬組成物への新規な使用
CA2599922A1 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
US20070105836A1 (en) * 2005-10-31 2007-05-10 Lars Pettersson Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
US20100016284A1 (en) 2006-12-20 2010-01-21 Astrazeneca Ab Compounds and uses thereof - 151
WO2008100715A1 (en) 2007-02-09 2008-08-21 Astrazeneca Ab Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-842之用途
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
RS52703B (sr) * 2008-06-20 2013-08-30 Astrazeneca Ab Derivat dibenzotiazepina i njegova upotreba

Similar Documents

Publication Publication Date Title
JP2011524898A5 (cg-RX-API-DMAC10.html)
JP2015501783A5 (cg-RX-API-DMAC10.html)
JP2007302689A5 (cg-RX-API-DMAC10.html)
JP2010077141A5 (cg-RX-API-DMAC10.html)
JP2013514980A5 (cg-RX-API-DMAC10.html)
JP2010529147A5 (cg-RX-API-DMAC10.html)
JP2009531376A5 (cg-RX-API-DMAC10.html)
JP2015505296A5 (cg-RX-API-DMAC10.html)
JP2010529118A5 (cg-RX-API-DMAC10.html)
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2013512277A5 (cg-RX-API-DMAC10.html)
JP2013518107A5 (cg-RX-API-DMAC10.html)
JP2020502092A5 (cg-RX-API-DMAC10.html)
CA2682494A1 (en) Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
JP2012504560A5 (cg-RX-API-DMAC10.html)
JP2012519182A5 (cg-RX-API-DMAC10.html)
JP2007516193A5 (cg-RX-API-DMAC10.html)
JP2013533253A5 (cg-RX-API-DMAC10.html)
JP2014526554A5 (cg-RX-API-DMAC10.html)
GB201020133D0 (en) Therapeutic use of compounds
JP2010521516A5 (cg-RX-API-DMAC10.html)
JP2008513510A5 (cg-RX-API-DMAC10.html)
JP2010527985A5 (cg-RX-API-DMAC10.html)
JP2015516419A5 (cg-RX-API-DMAC10.html)
JP2016508145A5 (cg-RX-API-DMAC10.html)